Search

everythinglearnresearchcommunity

for

Search:↓

Different types of resting melanocyte stem cells have unique characteristics and vary in their potential to become other cells.

Identified genes linked to male-pattern baldness may help develop new treatments.

Botulinum toxin A has limited effectiveness for 3 months in treating female pattern hair loss and may reduce scalp oiliness.

Genetic factors could lead to personalized treatments for hair loss.

Genetic analysis of rabbits identified key genes for traits like coat color, body size, and fertility.

Polymeric microneedles offer a less invasive, long-lasting drug delivery method that improves patient compliance and reduces side effects.

Stem cell treatment improved life quality and sexual function in women with hair loss.

The study concluded that the arachidonic acid pathway and the protein KRT79 play a role in determining the fineness of cashmere.

Many pediatric epilepsy patients experience preventable severe adverse drug reactions, especially with certain medications and risk factors.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

Hair camouflage methods like wigs and extensions can help Black women with alopecia feel better but may also damage hair if not used carefully.

Genes linked to wool fineness in sheep have been identified.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

Biopolymers are increasingly used in cosmetics for their non-toxicity and skin benefits, with future biotech advancements likely to expand their applications.

A woman had a unique skin growth with hair follicle, oil glands, fat cells, spindle cells, and nerve fibers.

Using platelet-rich plasma injections and 5% minoxidil topically can safely and effectively treat mild-to-moderate male pattern baldness.

Heat stress changes goats' skin and hair at the microscopic level and affects their genes and skin bacteria.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

New understanding and treatments for hair loss are improving, but more research is needed.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

People with hair loss conditions often have more mental health issues like depression and anxiety compared to those without hair loss.

The document lists common and scalp-specific lesions, emphasizing the need for hair restoration surgeons to recognize these and refer patients to a dermatologist if necessary.

Protein profiling of forehead skin can help distinguish between frontal fibrosing alopecia and androgenetic alopecia.

Using both PRP and minoxidil together works better for treating hair loss in men than using either one alone.

The document concludes that proper diagnosis and treatment of follicular disorders are crucial, with specific treatments for conditions like acne, drug-induced eruptions, and rosacea.

A lotion helped remove hair casts, which seem to come from a specific part of the hair follicle, and patients with hair casts can be grouped based on the cause.

Milia en plaque can be caused by skin damage, tumors, or external factors.

Hair loss in women links to inflammation around hair follicles.

Vav2 changes how hair follicle stem cells' genes work as they age, which might improve regeneration but also raise cancer risk.